Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator

Raman Sharma, John Litchfield, Karen Atkinson, Heather Eng, Neeta B. Amin, William S. Denney, John C. Pettersen, Theunis C. Goosen, Li Di, Esther Lee, Jeffrey A. Pfefferkorn, Deepak K. Dalvie and Amit S. Kalgutkar
Drug Metabolism and Disposition November 2014, 42 (11) 1926-1939; DOI: https://doi.org/10.1124/dmd.114.060087
Raman Sharma
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Litchfield
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Atkinson
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Eng
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neeta B. Amin
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William S. Denney
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Pettersen
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theunis C. Goosen
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Di
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Lee
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey A. Pfefferkorn
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepak K. Dalvie
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit S. Kalgutkar
Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 42 no. 11 1926-1939
DOI 
https://doi.org/10.1124/dmd.114.060087
PubMed 
25142735

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 16, 2014
  • Accepted August 19, 2014
  • Published online October 1, 2014.

Article Versions

  • Earlier version (August 20, 2014 - 10:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Raman Sharma,
  2. John Litchfield,
  3. Karen Atkinson,
  4. Heather Eng,
  5. Neeta B. Amin,
  6. William S. Denney,
  7. John C. Pettersen,
  8. Theunis C. Goosen,
  9. Li Di,
  10. Esther Lee,
  11. Jeffrey A. Pfefferkorn,
  12. Deepak K. Dalvie, and
  13. Amit S. Kalgutkar
  1. Pfizer Inc., Groton, Connecticut (R.S., K.A., H.E., J.C.P., T.C.G., L.D.), San Diego, California (D.K.D.), and Cambridge, Massachusetts (J.L., N.B.A., W.S.D., E.L., J.A.P., A.S.K.)
  1. Address correspondence to:
    Amit S. Kalgutkar, Pharmacokinetics, Dynamics, and Metabolism-New Chemical Entities, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139. E-mail: amit.kalgutkar{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201721742
Sep 201711210
Oct 201733920
Nov 201731716
Dec 20171269
Jan 201831914
Feb 201812116
Mar 201811610
Apr 201812712
May 201813420
Jun 20180283
Jul 201802119
Aug 201802419
Sep 201803713
Oct 201803622
Nov 20181179
Dec 201812514
Jan 201902312
Feb 201932212
Mar 201923016
Apr 201932124
May 201902421
Jun 201923412
Jul 201922826
Aug 201902719
Oct 20194126
Nov 201931212
Dec 2019112021
Jan 202062930
Feb 202011818
Mar 202012617
May 20200146
Jun 20202107
Jul 20200128
Aug 202001011
Sep 20201187
Oct 20202324
Nov 20202503
Dec 20202316
Jan 202142114
Feb 202139211
Mar 20213345
Apr 20212341
May 20211921
Jun 20211911
Jul 20212116
Aug 20211913
Sep 20212466
Oct 20211811
Nov 20212777
Dec 20212957
Jan 20224037
Feb 20221414
Mar 20224321
Apr 20221911
May 20221212
Jun 20222420
Jul 202228319
Aug 20222725
Sep 20222022
Oct 20221931
Nov 20222516
Dec 20221554
Jan 20232313
Feb 20231717
Mar 20232220

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 42 (11)
Drug Metabolism and Disposition
Vol. 42, Issue 11
1 Nov 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

MIST Analysis of a Glucokinase Activator

Raman Sharma, John Litchfield, Karen Atkinson, Heather Eng, Neeta B. Amin, William S. Denney, John C. Pettersen, Theunis C. Goosen, Li Di, Esther Lee, Jeffrey A. Pfefferkorn, Deepak K. Dalvie and Amit S. Kalgutkar
Drug Metabolism and Disposition November 1, 2014, 42 (11) 1926-1939; DOI: https://doi.org/10.1124/dmd.114.060087

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

MIST Analysis of a Glucokinase Activator

Raman Sharma, John Litchfield, Karen Atkinson, Heather Eng, Neeta B. Amin, William S. Denney, John C. Pettersen, Theunis C. Goosen, Li Di, Esther Lee, Jeffrey A. Pfefferkorn, Deepak K. Dalvie and Amit S. Kalgutkar
Drug Metabolism and Disposition November 1, 2014, 42 (11) 1926-1939; DOI: https://doi.org/10.1124/dmd.114.060087
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Antibiotics Induce Changes in the Expression of Rat DPGs
  • Metabolism of Efavirenz by P450s and UGTs in the Brain
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics